dehydroepiandrosterone

Preferred Label : dehydroepiandrosterone;

MeSH definition : A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.;

MeSH synonym : prasterone; 5 androsten 3 beta hydroxy 17 one; androstenolone; 5-androsten-3-beta-hydroxy-17-one; dehydroisoandrosterone; dhea;

MeSH Hyperonym : 5-Androsten-3-ol-17-one; 5 Androsten 3 ol 17 one;

Related MeSH term : prasterone, 3 alpha-Isomer; Prasterone, 3 alpha Isomer;

MeSH CAS label : Androst-5-en-17-one, 3-hydroxy-, (3beta)-;

MeSH Related Number : prasterone, 3 alpha-Isomer; 5-Androsten-3-ol-17-one; 2283-82-1 (3 alpha-isomer); 25375-38-6 (cpd w/o stereochem designation); 53-43-0 (Dehydroepiandrosterone);

Registry Number MeSH : 53-43-0;

Related CAS MeSH : 25375-38-6 (5-Androsten-3-ol-17-one); 2283-82-1 (Prasterone, 3 alpha-Isomer);

Wikipedia link : https://en.wikipedia.org/wiki/Dehydroepiandrosterone;

Codes EINECS : 200-175-5;

Is substance : O;

UNII : 459AG36T1B;

InChIKey : FMGSKLZLMKYGDP-USOAJAOKSA-N;

Details

Origin ID

D003687;

UMLS CUI

C0011185;

ATC code(s)
- prasterone [ATC Code]
- prasterone and estrogen [ATC Code]
ATC code(s)
- prasterone [ATC Code]
- prasterone [ATC Code]
- prasterone and estrogen [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- prasterone [Substance BNPC]
Fils d'après SNOMED CT
- androgens [MeSH Descriptor]
Pharmacological action(s)
- adjuvants, immunologic [MeSH Descriptor]
Record concept(s)
- 5-Androsten-3-ol-17-one [MeSH concept]
- dehydroepiandrosterone [MeSH concept]
- prasterone, 3 alpha-Isomer [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-hydroxydehydroepiandrosterone [MeSH Supplementary Concept]
- 15 beta-carboxyethylmercaptodehydroepiandrosterone [MeSH Supplementary Concept]
- 15-hydroxydehydroisoandrosterone [MeSH Supplementary Concept]
- 16-hydroxydehydroepiandrosterone [MeSH Supplementary Concept]
- 16-hydroxydehydroepiandrosterone sulfate [MeSH Supplementary Concept]
- 17-ethynyl-5-androstene-3, 7, 17-triol [MeSH Supplementary Concept]
- 3-(1,2-di-O-palmitoylglycero)sulfinylandrost-5-en-17-one [MeSH Supplementary Concept]
- 3-(1,2-di-O-palmitoylglycero)sulfonylandrost-5-en-17-one [MeSH Supplementary Concept]
- 3-(1,2-di-O-palmitoylglycero)thioandrost-5-en-17-one [MeSH Supplementary Concept]
- 3-(iodoacetoxy)dehydroisoandrosterone [MeSH Supplementary Concept]
- 3-acetoxyandrost-5-ene-7,17-dione [MeSH Supplementary Concept]
- 3-acetyl-7-oxodehydroepiandrosterone [MeSH Supplementary Concept]
- 3beta-acetoxyandrost-5-en-17-one [MeSH Supplementary Concept]
- 5-androstene-16-fluoro-17-one [MeSH Supplementary Concept]
- 7-carboxymethyl dehydroepiandrosterone [MeSH Supplementary Concept]
- 7-hydroxydehydroepiandrosterone [MeSH Supplementary Concept]
- 7-oxodehydroepiandrosterone [MeSH Supplementary Concept]
- 7alpha-amino-dehydroepiandrosterone [MeSH Supplementary Concept]
- Andro-6 [MeSH Supplementary Concept]
- BNN20 compound [MeSH Supplementary Concept]
- BNN23 compound [MeSH Supplementary Concept]
- BNN27 compound [MeSH Supplementary Concept]
- GL-701 [MeSH Supplementary Concept]
- HUM 5007 [MeSH Supplementary Concept]
- OH 8356 [MeSH Supplementary Concept]
- androst-5-en-17-one [MeSH Supplementary Concept]
- dehydroepiandrosterone acetate [MeSH Supplementary Concept]
- dehydroepiandrosterone enanthate [MeSH Supplementary Concept]
- dehydroepiandrosterone phosphatide [MeSH Supplementary Concept]
- dehydroepiandrosterone-3-O-methylthiophosphonate [MeSH Supplementary Concept]
- dehydroepiandrosterone-7-O-(carboxymethyl)oxime [MeSH Supplementary Concept]
- dehydroepiandrosterone-bovine serum albumin [MeSH Supplementary Concept]
- denosomin [MeSH Supplementary Concept]
- gonasterone [MeSH Supplementary Concept]
- gynodian [MeSH Supplementary Concept]
- immunor [MeSH Supplementary Concept]
- oleoyldehydroepiandrosterone [MeSH Supplementary Concept]
- sominone [MeSH Supplementary Concept]
- testosterone mustard [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Dehydroepiandrosterone Measurement [NCIt concept]
- Product containing dehydroepiandrosterone (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Hormone [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dehydroepiandrosterone [LOINC component]
- Dehydroepiandrosterone (substance) [SNOMED CT concept]
- Prasterone [ICD-11 Extension code]
- Prasterone [NCIt concept]
- Product containing dehydroepiandrosterone (medicinal product) [SNOMED CT concept]
- androstenolone [SNOMED Notion]
- dehydroepiandrosterone [SNOMED Notion]
- prasterone [ATC Code]
- prasterone [Substance BNPC]
- prasterone [ATC Code]
Validated automatic mappings to BTNT
- prasterone [ATC Code]
- prasterone [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients